Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.86M Sell
15,758
-317
-2% -$39.2K 0.16% 74
2025
Q4
$2.02M Sell
16,075
-1,267
-7% -$165K 0.17% 79
2025
Q3
$2.54M Sell
17,342
-157
-0.9% -$23.7K 0.21% 73
2025
Q2
$2.73M Buy
17,499
+463
+3% +$73.4K 0.26% 65
2025
Q1
$2.8M Buy
17,036
+159
+0.9% +$26.4K 0.69% 43
2024
Q4
$2.75M Buy
16,877
+1,430
+9% +$256K 0.21% 72
2024
Q3
$3.02M Sell
15,447
-4,044
-21% -$745K 0.25% 62
2024
Q2
$3.38M Sell
19,491
-845
-4% -$141K 0.28% 63
2024
Q1
$3.44M Buy
+20,336
New +$3.81M 0.29% 68

Other funds holding ZTS

American Trust's ZTS Position: Q1 2026 in Review

American Trust reduced its Zoetis (ZTS) stake by 2% in Q1 2026, selling an estimated $39.2K and leaving 15,758 shares worth $1.86M. The position accounts for 0.16% of the portfolio, ranked #74.

American Trust first reported a position in ZTS in Q1 2024 and has held it in 9 quarters since. The position peaked at $3.44M in Q1 2024. 1,604 funds tracked by Wall St. Rank hold ZTS as of Q1 2026.

  • American Trust held 15,758 shares of Zoetis worth $1.86M as of Q1 2026.
  • American Trust sold 317 Zoetis shares in Q1 2026, an estimated $39.2K.
  • Zoetis made up 0.16% of American Trust's portfolio in Q1 2026, its #74 holding.
  • American Trust first reported a position in Zoetis in Q1 2024 and has held it in 9 quarters since.
  • American Trust's Zoetis position peaked at $3.44M in Q1 2024.
  • 1,604 funds tracked by Wall St. Rank held Zoetis as of Q1 2026.

Based on American Trust's 13F filing for Q1 2026, filed 1 May 2026.